Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations von Torrice, Lindsay, Jalazo, Elizabeth

Volltext

INITIATION OF FLUOXETINE IN A PEDIATRIC PATIENT WITH MUCOPOLYSACCHARIDOSIS IIIA: EARLY OBSERVATIONS von Torrice, Lindsay, Jalazo, Elizabeth

Volltext

Exploring the optimal timing of treatment for attenuated MPS II: Learning from a late-diagnosed symptomatic adult vs asymptomatic infant identified by newborn screening von Torrice, Lindsay, Yerraguntla, Nitya, Clinard, Kristin, Bennick, Sarah, Jalazo, Elizabeth, Muenzer, Joseph

Volltext

Inconclusive endogenous nonreducing end GAG analysis in an infant detected on NBS for MPS I von Jalazo, Elizabeth E., Yerraguntla, Nitya E., Clinard, Kristin, Torrice, Lindsay, Bennick, Sarah, Muenzer, Joseph

Volltext

Challenges of disease severity prediction in an MPS II asymptomatic individual with a novel IDS variant: A unique NBS case with familial mosaicism von Clinard, Kristin, Yerraguntla, Nitya, Torrice, Lindsay, Bennick, Sarah, Weisenfeld, Leigh Anne, Jalazo, Elizabeth, Muenzer, Joseph

Volltext

North Carolina experience with newborn screening for mucopolysaccharidosis type II (Hunter syndrome) von Clinard, Kristin, Kucera, Katerina, Blake, Samantha, Copeland, Veronica, Migliore, Brooke, Torrice, Lindsay, Apoian, Julia, Tober, Kirstyn, Thorp, Evan, Blake, Kimberly, Bali, Deeksha, Pettit, Dee, Carter, Javan, Shone, Scott, Gehtland, Lisa, Jalazo, Elizabeth, Young, Sarah, Rehder, Catherine, Muenzer, Joseph, Raspa, Melissa

Volltext